Alkaline Earth Metal-Organic Frameworks with Tailorable Ion Release: A Path for Supporting Biomineralization.
Maria A MatlinskaMichelle HaBryden HughtonAnton O OliynykAbishek K IyerGuy M BernardGareth LambkinMason C LawrenceMichael J KatzArthur MarVladimir K MichaelisPublished in: ACS applied materials & interfaces (2019)
An innovative application of metal-organic frameworks (MOFs) is in biomedical materials. To treat bone demineralization, which is a hallmark of osteoporosis, biocompatible MOFs (bioMOFs) have been proposed in which various components, such as alkaline-earth cations and bisphosphonate molecules, can be delivered to maintain normal bone density. Multicomponent bioMOFs that release several components simultaneously at a controlled rate thus offer an attractive solution. We report two new bioMOFs, comprising strontium and calcium ions linked by p-xylylenebisphosphonate molecules that release these three components and display no cytotoxic effects on human osteosarcoma cells. Varying the Sr2+/Ca2+ ratio in these bioMOFs causes the rate of ions dissolving into simulated body fluid to be unique; along with the ability to adsorb proteins, this property is crucial for future efforts in drug-release control and promotion of mineral formation. The one-pot synthesis of these bioMOFs demonstrates the utility of MOF design strategies.
Keyphrases
- metal organic framework
- drug release
- bone mineral density
- drug delivery
- induced apoptosis
- postmenopausal women
- endothelial cells
- quantum dots
- ionic liquid
- soft tissue
- cell cycle arrest
- body composition
- bone loss
- quality improvement
- bone regeneration
- cell death
- cell proliferation
- oxidative stress
- pluripotent stem cells
- protein kinase
- pi k akt